Opendata, web and dolomites

ArtIST SIGNED

Pre-clinical evaluation and feasibility study for Artificial Inteligence-based Strain Typing and Bacterial Resistance analysis software

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ArtIST project word cloud

Explore the words cloud of the ArtIST project. It provides you a very rough idea of what is the project "ArtIST" about.

collaborative    edge    technologies    clover    fast    patients    leveraging    extensive    successfully    infectious    algorithms    antibiotics    cutting    tof    maldi    ms    diagnosis    ideal    efficient    worldwide    solution    resistant    standard    severe    hais    market    hospital    restricted    techniques    ours    perfect    player    confident    reducing    acquired    diagnosing    resistance    governments    stakeholders    sepsis    subspecies    infections    managers    acumen    identification    companies    expensive    investment    reference    background    data    public    vendor    modern    specific    region    power    wealth    clinical    universities    solid    solutions    scientific    raised    private    officials    prowess    health    biosoft    laboratories    time    network    microbiology    inception    government    consuming    revenues    ai    ripe    combination    big    integration    assisted    unable    first    combining    business    instruments    hospitals    software    diseases    bacterial    team    scientists    species    company    classify   

Project "ArtIST" data sheet

The following table provides information about the project.

Coordinator
CLOVER BIOANALYTICAL SOFTWARE SL 

Organization address
address: AVDA DE LA INNOVACION 1 EDIFICIO BIC OFFICE 135
city: GRANADA
postcode: 18016
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CLOVER BIOANALYTICAL SOFTWARE SL ES (GRANADA) coordinator 50˙000.00

Map

 Project objective

Specific bacterial subspecies, often resistant to traditional antibiotics, are the cause of severe problems like Hospital-Acquired Infections and sepsis. Reducing both time and costs for identification of these subspecies, thus diagnosing more efficiently infectious diseases, is crucial for our health systems. Current solutions in the field are based on expensive and time-consuming methods, and the fast, cost-efficient existing technologies, like MALDI-TOF MS, are restricted to the identification of main bacterial species, but are unable to go down to the subspecies level. Clover Biosoft is leveraging the power of modern AI techniques to develop algorithms using MALDI-TOF MS data to successfully classify bacterial subspecies. Ours is a collaborative project assisted by several first-level public hospitals and cutting-edge scientists from various European universities. Time-to-market is essential, and the market is ripe for our solution. MALDI-TOF MS instruments have become a standard in microbiology laboratories worldwide, allowing a very easy integration with our software. Moreover, the increasing number of patients affected by HAIs and the growing resistance to antibiotics, have raised the public concern, becoming a priority now for public and private health system managers and governments. Clover Biosoft is the ideal player to take this solution to the market, because of our long experience in the field and our extensive network, including all relevant type of stakeholders, from hospitals to big vendor companies and from researchers to government officials. Our team has the perfect combination of technical prowess, scientific background and business acumen. Our company has obtained solid revenues from its inception. Combining public and private investment, we are confident to take this project to market and become a reference for clinical diagnosis software development, bringing wealth and work to our region.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARTIST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARTIST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More